Elite Pharmaceuticals Inc (OTCQB:ELTP)

0.24
Delayed Data
As of Apr 01
 -0.005 / -2.04%
Today’s Change
0.17
Today|||52-Week Range
0.51
+6.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-13.6M-15.1M1.5M-96.6M
 
 
 
 
 
Depreciation483.5K484.2K423.3K453.7K
 
 
 
 
 
Total Other Cash Flow14.0M13.8M-2.7M91.9M
 
 
 
 
 
Funds From Operations892.6K-765.9K-793.9K-4.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-660.2K-371.8K1.1M-32.0K
 
 
 
 
 
Net Cash Flow - Operating Activities1.6M-394.1K-1.9M-4.2M
 
 
 
 
 
 
InvestingCapital Expenditures-1.0M-623.3K-153.0K-502.3K
 
 
 
 
 
Fixed Asset Disposal30.0K0.00----
 
 
Other Investing - Uses-343.6K0.00-1.000.00
 
 
 
Other Investing - Sources3.4K10.8K12.8K2.8K
 
 
 
 
 
Net Cash Flow Investing-1.4M-657.8K-191.8K-557.7K
 
 
 
 
 
 
FinancingShort Term Borrowings0.00-13.4K593.7K527.2K
 
 
 
 
Long Term Borrowings0.00--0.000.00--
Long Term Debt Reduction0.00--0.000.00--
Net Proceeds Stock Sale1.1M-92.2K1.0M10.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.00240.1K1.00
 
 
 
Other Uses - Financing13.1K0.000.0048.0K
 
 
 
Net Cash Flow - Financing1.0M-105.6K1.8M11.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash1.2M-1.2M-299.4K6.6M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account